LYN expression predicts the response to dasatinib in a subpopulation of lung adenocarcinoma patients

Therapies targeting SRC family kinases (SFKs) have shown efficacy in treating non-small cell lung cancer (NSCLC). However, recent clinical trials have found that the SFK inhibitor dasatinib is ineffective in some patient cohorts. Regardless, dasatinib treatment may benefit some NSCLC patient subgrou...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Kim, Yu Jin, Hong, Sungyoul, Sung, Minjung, Park, Min Jeong, Jung, Kyungsoo, Noh, Ka-Won, Oh, Doo-Yi, Lee, Mi-Sook, Oh, Ensel, Shin, Young Kee, Choi, Yoon-La
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5347739/
https://ncbi.nlm.nih.gov/pubmed/27756880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12657
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars